by swisschambei in Business
After a pandemic-related slump in 2020, Chinese companies last year spent more money on acquisitions or investments in Swiss companies. They invested a total of USD 96 million (CHF89 million) on nine deals. In 2020 they spent only USD 7 million on eight acquisitions or investments in Switzerland, according to a study published on Friday by consultants EY. Three of the nine transactions in 2021 were in the healthcare sector (pharma, biotech or medical technology), while there were two in consumer products and services. “In Switzerland in particular the healthcare sector is increasingly becoming one of the most important targets for Chinese companies because there’s a lot of catching up to be done in this area in China, especially in research and development,” said Hubert Stadler, head of EY’s China desk in Switzerland. This trend can be observed throughout Europe. The number of Chinese acquisitions and investments in the health sector increased from 16 in 2020 to 26 last year. Overall, Switzerland’s nine deals put it in sixth place; the previous year it shared fifth place with Italy and Spain. At the top, Britain (36 deals) overtook Germany (35).